Adlai Nortye (ANL) Cash & Current Investments (2022 - 2025)
Adlai Nortye's (ANL) quarterly Cash & Current Investments came in at $8.1 million in Q4 2025, down 86.77% year-on-year from $60.9 million in Q4 2024, and down 81.75% on a QoQ basis from $44.1 million in Q2 2025.
Adlai Nortye (ANL) Cash & Current Investments (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Cash & Current Investments data on file, last reported at $8.1 million in Q4 2025.
- On a quarterly basis, Cash & Current Investments fell 86.77% year-over-year to $8.1 million in Q4 2025; TTM through Dec 2025 was $8.1 million, a 86.77% decrease from a year earlier, with the FY2025 full-year figure at $8.1 million, down 86.77% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $8.1 million, down from $44.1 million in the prior quarter.
- Over the last five years, Cash & Current Investments for ANL reached as high as $98.0 million in Q2 2024 and fell as low as $8.1 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $61.1 million across 4 years, with a median of $62.5 million in 2022.
- Across the five-year window, Cash & Current Investments soared 42.87% in 2023 and tumbled 86.77% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $64.0 million in 2022, then surged by 42.87% to $91.5 million in 2023, then tumbled by 33.43% to $60.9 million in 2024, then tumbled by 86.77% to $8.1 million in 2025.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $8.1 million in Q4 2025, $44.1 million in Q2 2025, and $60.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.06 Mn |
| Jun 30, 2025 | 44.15 Mn |
| Dec 31, 2024 | 60.91 Mn |
| Jun 30, 2024 | 97.99 Mn |
| Dec 31, 2023 | 91.50 Mn |
| Dec 31, 2022 | 64.05 Mn |